![John Tagliamonte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Tagliamonte
Chief Executive Officer at Mellitus LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Renee Lentini | F | 46 | 20 years | |
Jose Halperin | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
Michael Chorev | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
Chris de Souza | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | 7 years |
Xing Zhao | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
Edwin Henrie | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
Page Gail | M | - |
Mellitus LLC
![]() Mellitus LLC BiotechnologyHealth Technology Mellitus LLC develops vitro diagnostic tests for the measurement of Glycated CD59 (GCD59). Its vitro diagnostic test is also used for the stratification of complications risk and as a clinical trial test for pharmaceutical development. The company was founded by Jose Alberto Halperin, Joyce A. Lonergan and Michael Chorev in 2011 and is headquartered in Boston, MA. | - |
George Davy | M | 72 | 23 years |
Connections Chart
Multi-company connection
Former connections
Statistics
Country | Connections | % of total |
---|---|---|
United States | 95 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Tagliamonte
- Personal Network